Fowler Neal Franklin 4
4 · Emergent BioSolutions Inc. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Emergent BioSolutions (EBS) Director Neal Fowler Receives RSU and Option Award
What Happened
Neal Fowler, a member of the Emergent BioSolutions (EBS) board of directors, received annual equity awards on April 30, 2026: 25,344 restricted stock units (RSUs) and 11,296 stock options. The reported acquisition price is $0.00 because these were grants (not purchases); the combined award equals 36,640 equity instruments. Both the RSUs and the options vest on the day before the one-year anniversary of the grant, provided Fowler remains a board member through that date.
Key Details
- Transaction date: 2026-04-30; Form 4 filed 2026-05-04 (timely — within the two business-day reporting window).
- Grants: 25,344 RSUs (award, $0.00) and 11,296 stock options (derivative grant, $0.00). Total instruments: 36,640.
- Shares/ownership after transaction: not disclosed in the filing.
- Footnotes:
- F1 — RSUs: each RSU converts into one share upon vesting; vesting on the Annual Grant Vesting Date (day before one-year anniversary) contingent on board service.
- F2 — Options: each option is a right to purchase one share at the option exercise price; options vest on the same Annual Grant Vesting Date.
- F3 — Option count was set by taking 25% of the non‑employee director compensation value and dividing by a Black‑Scholes option value calculated at grant.
Context
These are routine, annual non-employee director compensation awards (a common way companies pay outside directors). RSUs represent future stock deliveries on vesting; the granted options give the right to buy shares at a set exercise price upon vesting. Because these are grants (not open-market buys or sales), they reflect standard compensation rather than an immediate market sentiment signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-30+25,344→ 160,847 total - Award
Stock Option (Right to Buy)
[F2][F3]2026-04-30+11,296→ 11,296 totalExercise: $7.99Exp: 2033-04-30→ Common Stock (11,296 underlying)
Footnotes (3)
- [F1]Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
- [F2]Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
- [F3]The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.